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Sp3 is a ubiquitously expressed transcription factor
closely related to Sp1 (specificity protein 1). We have
disrupted the mouse Sp3 gene by homologous recomb-
ination. Sp3-deficient embryos are growth retarded
and invariably die at birth of respiratory failure.
The cause for the observed breathing defect remains
obscure since only minor morphological alterations
were observed in the lung, and surfactant protein
expression is indistinguishable from that in wild-type
mice. Histological examinations of individual organs
in Sp3–/– mice show a pronounced defect in late tooth
formation. In Sp3 null mice, the dentin/enamel layer
of the developing teeth is impaired due to the lack of
ameloblast-specific gene products. Comparison of the
Sp1 and Sp3 knockout phenotype shows that Sp1 and
Sp3 have distinct functions in vivo, but also suggests a
degree of functional redundancy.
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Introduction
Many housekeeping, tissue-specific and viral genes contain
functionally important GC and related GT/CACC boxes. It
has been known for some time that the general transcription
factor Sp1 (specificity protein 1) (Kadonaga et al., 1987)
can bind to and act through these elements, and it was
generally accepted that Sp1 is involved in the expression
of many different genes. More recently, however, it became
clear that Sp1 is not the only protein acting through ‘Sp1-
binding sites’ but represents the first identified and cloned
protein of a large, still growing family of transcription
factors united by the presence of a highly conserved DNA-
binding domain consisting of three zinc fingers. This Sp/
XKLF superfamily of proteins includes the Sp transcription
factors, their close relatives BTEB1, TIEG1 and TIEG2,
and the Kru¨ppel-like factors (reviewed in Philipsen and
Suske, 1999).
The Sp subfamily of transcription factors is composed
of four proteins (Sp1, Sp2, Sp3 and Sp4) characterized
© European Molecular Biology Organization 655
by very similar structural features (Suske, 1999). In
addition to the highly conserved DNA-binding domain,
all four proteins contain glutamine-rich activation domains
adjacent to serine/threonine-rich stretches in their
N-terminal region. The linkage to the four human Hox
gene clusters also documents their close evolutionary
relationship (Kalff-Suske et al., 1995, 1996; Scohy et al.,
1998). Sp1, Sp3 and Sp4 are more closely related to each
other than to Sp2 (Philipsen and Suske, 1999; Suske,
1999). Consistently, Sp1, Sp3 and Sp4 recognize the
classical GC box and the related GT/CACC box with
identical affinity (Hagen et al., 1992, 1994). Sp3 and Sp1
are ubiquitously expressed, unlike Sp4, which shows a
complex expression pattern but is most abundant in
neuronal tissues (Supp et al., 1996).
A large variety of biological functions have been
assigned to Sp1-binding sites. This raises the question of
which of the tasks are performed by which protein in vivo.
This question is particularly interesting for Sp1 and Sp3
because both proteins are ubiquitously expressed. Mice
lacking Sp1 and Sp4 have been reported (Supp et al.,
1996; Marin et al., 1997). The most interesting aspect of
the Sp4 phenotype is the complete absence of mating
behavior in Sp4 null males. Since their reproductive organs
are fully developed and apparently normal, the most likely
cause of this behavioral abnormality is a neurological
defect.
Sp1 null embryos are severely growth retarded, and die
after day 10 of embryonic development (E10). They
display a wide range of abnormalities, but all characteristic
hallmarks up to this developmental stage are present.
Blastocyst injections of Sp1 null embryonic stem (ES)
cells showed that these cells contribute efficiently to early
chimeric embryos, but after embryonic day 11 (E11) this
declines very rapidly with no detectable contribution to
any tissue of newborn animals. Thus, Sp1 deficiency
causes a cell-autonomous defect, and it appears that Sp1
function is generally required for cellular survival after
E10 (Marin et al., 1997).
It was surprising that the Sp1 null embryos survive
until the post-implantation stage. More than 3000 publica-
tions have implicated this factor in the activation of a
very large number of genes and in cellular processes such
as cell cycle regulation, chromatin remodeling and the
propagation of methylation-free CpG islands. Thus, a cell
lacking Sp1 would be predicted to stand little chance of
surviving, but surprisingly Sp1 null ES cells have normal
growth characteristics and survival rates. It has been
suggested that this might be due to the presence of
Sp3, the most closely related Sp family member (Marin
et al., 1997).
Sp3 has been shown to act as a transcriptional activator
on many promoters similarly to Sp1 (e.g. Udvadia et al.,
1995; Liang et al., 1996; Ihn and Trojanowska, 1997;
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Zhao and Chang, 1997). In other promoter settings,
however, Sp3 remained inactive or acted only as a weak
activator (e.g. Hagen et al., 1994; Majello et al., 1994;
Dennig et al., 1995; Kumar and Butler, 1997). Biochem-
ically, the most obvious differences between Sp3 and Sp1
are the presence of a potent inhibitory domain in Sp3
(Dennig et al., 1996) and the existence of three Sp3
isoforms (Kennett et al., 1997; Suske, 1999). However,
the significance of these differences for in vivo functions
remains an open question.
Here we describe the targeted disruption of the mouse
Sp3 gene by homologous recombination and analysis of
Sp3 null mice. We find that the absence of Sp3 has
consequences for mouse development that are very differ-
ent from those observed in Sp1 knockout mice. Sp3
null mice develop until birth with no obvious gross
abnormalities other than a reduction in body weight. After
natural birth or Caesarian section, the knockout mice
invariably die within 10 min, apparently of respiratory
failure. Histological examination revealed minor structural
abnormalities in the lungs. Furthermore, the mice show a
pronounced defect in dentin/enamel layer formation of the
developing teeth. We conclude that Sp1 and Sp3 may
have similar, and therefore redundant, functions during
early development but exert distinct and highly specific
functions in later developmental stages.
Results
Isolation of mouse Sp3 gene fragments
Primers derived from the human Sp3 cDNA were used to
amplify a fragment of the mouse Sp3 gene by PCR. The
primers A3/K (5-CAGATCATTCCTGGCTCT-3) and
A3/L (5-TCTAGATCGACACTATTGAT-3) that pro-
duced a unique 210 bp fragment with human and mouse
genomic DNA were used to screen a genomic mouse ES
cell P1 phage library (Genome Systems Inc.). A single
P1 clone of ~80 kbp was mapped and several fragments
were subcloned into the Bluescript KS vector. Sequence
analyses revealed that both activation domains of Sp3 are
encoded by a single large exon (Figure 1A).
Targeted disruption of the mouse Sp3 gene
The target vector pBS-P-B-∆-lacZ-neo-5-Sp3 (Materials
and methods) was designed to substitute exon 2 [amino
acids 38–490 according to Yajima et al. (1998)] of the
murine Sp3 gene for IRES-LacZ-neo-polyA sequences
(Figure 1A). The lacZ–neo fusion gene is expressed under
the control of the endogenous Sp3 promoter. The deleted
sequences encode both glutamine-rich activation domains
of Sp3 (Dennig et al., 1996). Thus, the disruption should
result in a null allele.
Plasmid pBS-P-B-∆-lacZ-neo-5-Sp3 was linearized at
a unique NotI site present in the vector for transfection
into E14 ES cells. Cells were maintained subsequently
under G418 selection. A total of 36 G418-resistant colonies
were analyzed by Southern blotting for the homologous
recombination event. Hybridization of EcoRI-restricted
DNA from individual clones with an EcoRI–PstI intron
fragment was predicted to show a 11 kbp fragment from
the wild-type locus and a 5.4 kbp fragment from a correctly
targeted locus (Figure 1A). Fourteen clones showed the
predicted mutant fragment of 5.4 kbp (Figure 1B). In
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Fig. 1. Targeted disruption of the mouse Sp3 gene. (A) Schematic
representation of the Sp3 protein structure. The glutamine-rich
activation domains A and B, the inhibitory domain (ID) and the zinc
fingers (black bars) of the DNA-binding domain (DBD) are indicated.
Connecting lines with the corresponding murine Sp3 gene regions
indicate the derivation of the N-terminal part of the Sp3 protein. Both
glutamine-rich activation domains (A and B) are encoded by a single
large exon. In the targeting vector, this exon was replaced by a
cassette containing a splice acceptor site (SA), an internal ribosomal
entry site (IRES) and a lacZ–neo fusion gene (LacZ Neo) (Mountford
et al., 1994). The positions of relevant restriction sites (B, BamHI; E,
EcoRI; H, HindIII; P, PstI; N, NotI) and the probe used for Southern
blotting are indicated. Restriction of genomic DNA with EcoRI and
hybridization with the indicated probe detects a 11 kbp fragment of
the wild-type allele and a 5.4 kbp fragment of the mutated allele.
(B) Southern blot analysis of targeted ES cells. (C) PCR analysis of
mouse embryos. The primers produce a 273 bp DNA fragment from
the wild-type and a 593 bp fragment from the targeted allele.
addition, PCR analysis with a set of primers specific for
the wild-type and the targeted Sp3 gene (Figure 1C)
confirmed the targeted disruption of the mouse Sp3 gene.
Two of the targeted ES clones with the correct karyotype
were injected into C57BL/6 blastocysts. Breeding of the
chimeras revealed germline transmission of the mutated
Sp3 allele. Mating of heterozygous animals resulted in
embryos deficient in all three Sp3 isoforms (Figure 2).
Mice lacking Sp3 die immediately after birth due
to respiratory failure
Heterozygous Sp3/– mice derived from male germline
chimeras exhibited no discernible phenotype. Sp3-deficient
mice derived from heterozygous matings were not viable
(Table I). Genotyping of embryos obtained by Caesarian
section shortly before the parturition date (E18.5) showed
no statistically significant loss of Sp3–/– mice up to birth
(Table I). The weight of these pups was ~25% lower than
that of their wild-type littermates (Figure 3; Table II).
Close monitoring of E18.5 embryos after Caesarian
section and of litters after birth revealed that Sp3–/– mice
Post-natal lethality of Sp3 knockout mice
Fig. 2. Sp3 protein expression in wild-type and Sp3 mutant mice.
(A) Western blot analysis of wild-type, Sp3/– and Sp3–/– animals.
Nuclear extracts (6 µg of protein) from brains of wild-type (WT),
heterozygous (Sp3/–) and Sp3-deficient (Sp3–/–) mice were
fractionated through 7.5% SDS–polyacrylamide gels, stained with
Coomassie Blue (lanes 1–4; M, marker lane) or blotted on
nitrocellulose filter and incubated with Sp3-specific antibodies (lanes
5–7). (B) Electrophoretic mobility shift assay of GC box binding
activity in wild-type (WT) and Sp3-deficient (Sp3–/–) mouse
embryonic fibroblasts. Crude nuclear extracts (1.25 µg of protein)
were incubated with 32P-labeled GC box oligonucleotide in the
absence (lanes 8 and 11) or presence of antisera against Sp1 (lanes 9
and 12, αSp1) or a mixture of antisera against Sp1 and Sp3 (lanes 10
and 13, αSp1/3).
Table I. Genotype distribution of Sp3 heterozygous crossings
Total / /– –/–
E18.5 242 70 (28.8%) 115 (47.1%) 57 (23.4%)
Day 10 68 24 (35.3%) 44 (64.7%) 0 (0%)
The genotype was determined by PCR analysis as described in
Materials and methods.
were born alive and made visible efforts to breathe.
In contrast to their wild-type and heterozygous littermates,
the Sp3 null mice died within 10 min post-partum. The
duration of the pregnancy was prolonged by up to 2 days
with progesterone injections in an attempt to promote the
maturation of the Sp3 null fetuses. However, this did not
rescue the neonatal lethality of the knockout mice.
Expression of lung-specific genes is not affected in
Sp3–/– mice
Lung tissue dissected from several mutant neonates
obtained from independent litters failed to float on water,
indicating that the alveoli were never filled with air.
Histopathological examination of the lung (Figure 4)
revealed that lung tissue of Sp3 null mice is more compact,
featuring a smaller mean alveolar space diameter and
thicker septa between the alveoli. In addition, fewer
capillaries are observed in Sp3–/– lung tissue, but instead
abnormal cubical pale cells are present at the inner surface
of the alveoli. Ultrastructural analysis of these cells shows
disruption of the apical membrane along with a small rim
of cytoplasm leading to an artificial intracellular space
filled with slightly electron-dense material (Figure 4).
The histopathological examination suggests that the
inability of the Sp3–/– mice to breathe might be attributed
to an intrinsic inability of the lungs to expand. We have
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examined the presence of transcripts encoding surfactant
and other lung-specific proteins involved in lung develop-
ment and function. Northern blot analyses of RNA from
E18.5 mice revealed that expression of surfactant proteins
A, B, C and D, and the transcription factors, thyroid
transcription factor 1 (TTF-1), which is highly expressed
in lung Clara cells, and lung Kru¨ppel-like factor (LKLF),
was not affected in lungs of Sp3–/– embryos (Figure 5).
In addition, elastin and p21 mRNAs were expressed at
normal levels (data not shown). The only transcript that
was slightly reduced (2-fold) was uteroglobin/Clara cell
secretory protein (UG/CCSP). However, uteroglobin/
CCSP-deficient mice develop normally and are apparently
healthy (Stripp et al., 1996). Thus, the 2-fold lower
expression of uteroglobin/CCSP cannot account for the
breathing failure. In conclusion, the molecular cause of
the respiratory defect remains unknown at present.
Impact on tooth development
In the course of analyzing histological sections of mouse
E18.5 embryos, we observed a morphological deviation
in the developing teeth of Sp3–/– mice. In our sections,
the dentin/enamel layer of the teeth is generally disrupted
from the ameloblast cells in wild-type mice, leading to
the creation of an artificial empty space (Figure 6). This
was not observed in Sp3 null mice. At late embryonic
stages, the processes of dentinogenesis (dentine formation)
and amelogenesis (enamel formation) take place. Close
inspection of the sections revealed that the developing
teeth of wild-type mice contain a continuous row of
ameloblasts and a row of odontoblasts interrupted by
small vessels (Figure 6A). Two layers of differentially
stained pink and purple material, consisting of predentin,
dentin and enamel, are visible between the ameloblasts
and odontoblasts (Figure 6C). In Sp3–/– mice, only a few
vessels are observed and the odontoblasts are arranged in
a continuous row. Most significantly, teeth of Sp3–/– mice
contain only the pink layer and lack the purple layer
(Figure 6D).
Lack of ameloblast-specific transcripts in Sp3–/–
mice
Odontoblasts and ameloblasts express genes that are
required to form the dentin and the enamel extracellular
matrix, respectively. We asked whether the altered dentin/
enamel layers in sections of teeth from Sp3–/– mice
might reflect the lack of odontoblast- and/or ameloblast-
specific gene products. Amelogenin (Snead et al., 1983;
Couwenhoven and Snead, 1994) and ameloblastin
(Krebsbach et al., 1996; Lee et al., 1996) are ameloblast-
specific gene products involved in enamel formation. The
dentin-matrix protein 1 (DMP1) is expressed specifically
in odontoblasts (MacDougall et al., 1998a). Tuftelin, yet
another specialized protein secreted into the developing
enamel matrix, is also synthesized in odontoblasts at this
stage of development (Diekwisch et al., 1997). Northern
blot analyses were performed with RNA extracted from
jaws or heads of newborn mice and of E18.5 embryos
(Figure 7). Amelogenin and ameloblastin mRNA was
detectable at birth (Figure 7A and B) and at E18.5
(Figure 7E and F) in wild-type and heterozygous mice
but not in Sp3–/– mice. In accordance with published data,
hybridization with the ameloblastin-specific probe detected
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Fig. 3. Sp3 mutant E18.5 embryos. Genotyped E18.5 embryos of one litter that are wild-type (/), heterozygous (/–) or homozygous (–/–) for
the targeted Sp3 gene locus. Homozygous mutants are ~25% smaller than wild-type and heterozygous embryos.
Table II. Weight of embryos (g) of Sp3 heterozygous crossings
/ /– –/–
E13.5 0.16, SD  0.02, 0.15, SD  0.02, 0.12, SD  0.02,
n  19 n  31 n  15
E18.5 1.10, SD  0.16, 1.05, SD  0.14, 0.72, SD  0.08,
n  18 n  39 n  17
two distinct transcripts that were both expressed only in
teeth (Krebsbach et al., 1996). The odontoblast-specific
transcript encoding DMP1 (MacDougall et al., 1998a) as
well as transcripts encoding tuftelin (Diekwisch et al.,
1997; Zeichner-David et al., 1997; MacDougall et al.,
1998b) were detectable at similar intensities in wild-
type, Sp3/– and Sp3–/– mice (Figure 7C and D). Thus,
ameloblast-specific but not odontoblast-specific gene prod-
ucts are missing in Sp3-deficient mice. These results
strongly suggest that the absence of ameloblast-specific
proteins contributes to the observed histological tooth
phenotype in Sp3–/– mice.
Discussion
Sp3-deficient mice are not viable
Our results demonstrate that the ubiquitous transcription
factor Sp3 is essential for immediate post-natal survival
of mice. Sp3–/– mice were found in expected Mendelian
ratios until birth, but they all died within a few minutes
post-partum due to respiratory failure. The molecular
cause for the observed breathing defect of the Sp3–/–
mutants remains obscure. Only slight morphological altera-
tions were observed in the lung that we attributed initially
to developmental delay. However, a prolonged pregnancy
did not rescue the lethal phenotype. In addition, surfactant
protein gene expression in lung of Sp3 mutant mice was
apparently indistinguishable from that in wild-type mice.
Thus, undiscovered physiological alterations, such as in
the enervation of respiratory muscles, are more likely to
be responsible for the respiratory failure of Sp3 null mice.
Tooth development is impaired in Sp3-deficient
mice
Our analyses of Sp3-deficient embryos provide evidence
that Sp3 plays an essential role in late tooth development.
Newborn Sp3–/– embryos show only partial formation of
the dentin/enamel layer, indicating that dentinogenesis or
amelogenesis (dentin and enamel formation) is impaired.
A consequence of epithelial cell differentiation into amelo-
blasts is the expression of proteins that form the enamel
extracellular matrix, a scaffold required to nucleate calcium
phosphate salts to form calcium hydroxylapatite. Although
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Fig. 4. Histological and ultrastructural analyses of lung tissue in wild-
type and Sp3–/– mice. Lung tissue at E18.5 of wild-type (WT) (A, C
and E) and Sp3 knockout mice (–/–) (B, D and F) is shown in
histological sections stained with hematoxylin and eosin (A–D), or in
ultrastructural sections (E and F). At low magnification (A and B),
lung tissue from Sp3–/– mice is more compact, with a smaller mean
diameter of alveolar spaces and a thicker septum between individual
alveoli. At higher magnification (C and D), capillaries are regularly
seen at the inner surface of the alveoli in wild-type mice (C, arrow).
Lung tissue from Sp3-deficient mice exhibits small alveoli with the
inner surface lined with cuboid pale cells (D, arrowheads).
Ultrastructural analysis revealed that the apical membranes of these
cells together with a small rim of cytoplasm (F, large arrows) are
disrupted from their original location near the nucleus (N, small
arrows in F). These lead to artificial intracellular spaces (asterisks)
filled with slightly electron-dense material. In wild-type lung tissue, a
regular air–blood boundary (between arrowheads in E) consisting of an
endothelial cell, a basement membrane and a pneumocyte type I is
observed. An erythrocyte (‘Er’ in E) filling the space of a capillary
and surfactant (‘S’ in E and F) are indicated. Bar in (A) and
(B), 100 µm; in (C) and (D), 10 µm; in (E) and (F), 0.5 µm.
Post-natal lethality of Sp3 knockout mice
Fig. 5. Expression of putative Sp3 target genes in the lung. RNA was
extracted from lungs of wild-type (/), Sp3/– (/–) and Sp3-
deficient (–/–) E18.5 embryos, subjected to electrophoresis through 1.2
or 0.8% formaldehyde–agarose gels and transferred to nylon
membranes. The filters were hybridized with cDNA fragments of
surfactant proteins A (SP-A), B (SP-B), C (SP-C) and D (SP-D),
uteroglobin/Clara cell secretory protein (UG/CCSP; two different
membranes), lung Kru¨ppel-like factor (LKLF) and thyroid
transcription factor (TTF-1). As a control, the filters were probed with
an 18S rRNA-specific oligonucleotide.
the ameloblast cell layer is present in Sp3–/– mice, the
ameloblast-specific products amelogenin and ameloblastin
are absent. In contrast, the odontoblast-specific gene
products DMP1 and tuftelin are present in Sp3 null
embryos. At this stage, we do not know whether Sp3
functions as a direct regulator of ameloblast-specific genes.
Recently, the cloning and preliminary characterization of
the murine ameloblastin (Dhamija et al., 1999) and the
amelogenin promoter (Chen et al., 1998) have been
reported. The ameloblastin promoter contains a potential
Sp3-binding site (CACCC box) in a promoter region that
contributes to its cell type-specific expression. Thus, the
amelogenin and ameloblastin genes might be direct targets
of Sp3.
Physiological functions of Sp1 and Sp3
Sp3 is a ubiquitously expressed transcription factor with
structural features similar to Sp1. Sp1 and Sp3 recognize
the same DNA elements and, in many reports, Sp3 has
been shown to act as a potent transcriptional activator
similar to Sp1 (Udvadia et al., 1995; Liang et al., 1996;
Ihn and Trojanowska, 1997; Zhao and Chang, 1997). The
physiological function of Sp1 and Sp3, however, appears
to be significantly different. In contrast to Sp3 null mice,
Sp1-deficient embryos are already severely retarded at
early embryonic stages and die around day 10–11 of
gestation (Marin et al., 1997). Thus, the obvious structural
similarity, the common DNA recognition sites and the
ubiquitous expression of Sp1 and Sp3 do not reflect
identical physiological functions. Nevertheless, there still
might be many overlapping functions of Sp1 and Sp3
in vivo. The Sp1 and Sp3 knockouts demonstrate that each
protein on its own is not responsible for the expression
of a very large number of essential genes, such as
housekeeping, tissue-specific and cell cycle-regulated
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Fig. 6. Histological analysis of developing teeth in wild-type and
Sp3–/– mice. Teeth at E18.5 of wild-type (A and C) and Sp3-deficient
mice (B and D) are shown in histological sections stained with PAS.
At low power magnification, the developing tooth of wild-type mice
shows a continuous row of ameloblasts (‘Am’, arrow) and
odontoblasts (‘Od’, arrow) interrupted by small vessels interspersed
between the odontoblasts (black arrowheads in C). Between the
ameloblasts and odontoblasts, a sheet of pink and purple stained
material that contains dentin and enamel is visible (marked in A and C
by two white arrowheads). This layer of secretory products has been
disrupted from the ameloblasts, leaving an artificial space (asterisks in
A and C) that is regularly observed in wild-type mice of this age, but
not in Sp3 null mice. In contrast, Sp3 knockout mice show only a pink
layer (white arrowheads in B and D). In addition, only a few vessels
are observed in the dental papilla, leaving the odontoblasts in a
continuous row (‘Od’ with arrow in B and bottom cell layer in D).
(E–H) PAS-stained histological sections of E18.5 tissues with no
obvious morphological alterations in knockout mice. (E and
F) Pancreas. (G and H) Liver; the arrow in (H) points to a
megakaryocyte. Liver cells have a pale cytoplasm and are interspersed
by small clusters of hematopoetic cells. Bar in (A) and (B), 100 µm;
in (C) and (D), 10 µm; in (E–H), 30 µm.
genes. This suggests that Sp1 and Sp3 have a wide range
of redundant functions that can compensate for each other
in Sp1 and Sp3 knockout mice.
Another, tissue-restricted member of the Sp family
of transcription factors, Sp4, might also contribute to
redundancy in vivo. Sp4, although expressed predomi-
nantly in the brain, is also detectable in epithelial tissues,
testis and developing teeth (Supp et al., 1996). Disruption
of the mouse Sp4 gene revealed that Sp4 is also important
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Fig. 7. Expression of putative Sp3 target genes in teeth. RNA was
extracted from head or jaws of wild-type (/), Sp3/– (/–) and
Sp3-deficient (–/–) newborn or E18.5 embryos, subjected to
electrophoresis through 1.2% formaldehyde–agarose gels and
transferred to nylon membranes. The filters were hybridized with
cDNA fragments encoding ameloblastin (A and E), amelogenin (B and
F), DMP1 (C) and tuftelin (D). As a control, the filters were probed
with an 18S rRNA-specific oligonucleotide.
for early post-natal survival since approximately two-
thirds of the Sp4–/– mice die within a few days after
birth for unknown reasons (S.Philipsen and G.Suske,
unpublished data). So far, essential target genes for Sp4
have not been identified.
On many reporter constructs containing multiple Sp-
binding sites, Sp3, unlike Sp1, is inactive or acts only as
a weak activator. The molecular basis for the inactivity
of Sp3 under these conditions has been mapped to an
inhibitory domain located between the second glutamine-
rich activation domain and the zinc finger region (Dennig
et al., 1996). The integrity of a charged amino acid triplet
(KEE) within this domain is absolutely essential for
inhibitor function. Mutation of these amino acids converts
Sp3 to a strong activator (Dennig et al., 1996) that is
almost indistinguishable from Sp1. A most intriguing
possibility would be that this molecular difference between
Sp1 and Sp3 reflects the differences in their physiological
functions. Can a mutant of Sp3 lacking the inhibitory
domain rescue the Sp1 knockout? The generation of
transgenic lines expressing different isoforms and mutants
of Sp3 and intercrossings with heterozygous Sp1, Sp3 and
Sp4 mice could provide new insight into the physiological
and biochemical relationships between these three tran-
scription factors.
The early embryonic lethality of Sp1 knockout mice
and the post-natal lethality of Sp3 knockout mice preclude
the analysis of later developmental stages. In order to
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achieve this, conditional disruption of the Sp1 and Sp3
genes in specific tissues at any given stage of development,
as well as the generation of compound knockouts of Sp1,
Sp3 and Sp4 will be an important step to unravel further
the physiological roles of these proteins in vivo.
Materials and methods
Generation of the Sp3 homologous recombination construct
As starting plasmid, we chose the Bluescript derivative pBS4.5BamHI
that contains a 4.5 kb BamHI fragment encoding both glutamine-rich
activation domains on a single exon and ~1 kbp upstream and 2.5 kbp
downstream intron sequences of the Sp3 gene locus (see Figure 1A).
We removed the exon and the 5 intron sequences by restriction with
PstI and re-ligation, leading to pBS-P-B. β-galactosidase sequences
within the Bluescript vector that may interfere with the lacZ gene (see
below) were removed by NaeI and KspI restriction, Klenow filling and
re-ligation (plasmid name: pBS-P-B-∆). Next, we introduced an IRES-
LacZ-neo cassette obtained as a 7.3 kbp SalI fragment from the plasmid
pGT1.8Iresβgeo (Mountford et al., 1994) into the SalI polylinker site of
pBS-PstI–BamHI∆lacZ, leading to pBS-P-B-∆-lacZ-neo. In a final step,
we cloned 5 intron sequences of the Sp3 gene as a 1.7 kbp HindIII–
BamHI fragment into the XhoI polylinker site of pBS-P-B-∆-lacZ-neo
using XhoI linkers, leading to the knockout construct pBS-P-B-∆-lacZ-
neo-5-Sp3. For transfection into ES cells, the plasmid was linearized
with NotI.
Transfection and selection of ES cells
E14 ES cells were electroporated with 15 µg of NotI-linearized targeting
vector pBS-P-B-∆-lacZ-neo-5-Sp3. Clones were selected with G418
(200 µg/ml) and homologous recombination was analyzed by Southern
blotting of EcoRI-restricted genomic DNA with the probe indicated in
Figure 1. Unwanted random integrations were detected by hybridizing
these blots with a Bluescript vector-specific probe.
Generation of chimeric and Sp3-deficient mice
Sp3/– ES cell clones were karyotyped, and two clones (#10 and #38)
were microinjected in C57BL/6 host blastocysts. Chimeric males were
mated to C57BL/6 females. Germline transmission was obtained with
both clones. The F1 offspring were interbred to expand the stocks. No
viable Sp3 null animals were obtained with mice derived from clones
#10 and #38. Preliminary in utero analysis of Sp3 null fetuses revealed
no obvious differences between the two lines. For the analyses presented
herein, we have used line #10. To extend the duration of pregnancy,
pregnant females received daily subcutaneous injections of progesterone
(5 mg/kg body weight) from day 16 after discovery of the vaginal plug.
Pregnancies extended 2 days beyond their normal duration were delivered
by Caesarian section.
Genotyping of embryos by PCR
DNA was prepared from tail snips and analyzed for the presence of the
wild-type and knockout Sp3 allele by PCR. Three primers were used: a
sense primer in the Sp3 gene amplifying the wild-type allele
(5-ACTACTAGTGGGCAAGTCCA-3), a sense primer in the neo gene
amplifying the knockout allele (5-AGCGCATCGCCTTCTATCG-3)
and an antisense primer in the Sp3 gene (5-TACCATTGCACA-
TTTAATGA-3). PCR conditions were 94°C, 1 min; 60°C, 1 min; 72°C,
1 min; for 30 cycles.
Nuclear extracts and gel retardation assays
Nuclear extracts were prepared according to Andrew and Faller (1991).
Electrophoretic mobility shift assays (EMSAs) were performed by pre-
incubating 1–3 µl of nuclear extract with 1.5 µg of unspecific competitor
poly(dI–dC) in a buffer containing 10 mM HEPES pH 7.9, 150 mM
KCl, 1 mM dithiothreitol (DTT), 0.5 mM MgCl2, 0.1 mM EDTA, 8.5%
glycerol for 10 min on ice. Subsequently, 0.1 ng of 32P-labeled double-
stranded GC box oligonucleotide was added to a final volume of 20 µl,
and samples were incubated for another 20 min on ice. Antisera against
Sp1 and Sp3 used for supershift assays were described previously (Hagen
et al., 1994). Usually, 1 µl of the appropriate antiserum was added to
the binding reaction, and incubation was continued at room temperature
for another 20 min. Samples were analyzed on 4% native polyacrylamide
gels in 45 mM Tris, 45 mM boric acid, 1.6 mM EDTA. Gels were
transferred to Whatman 3MM paper, dried under heat and vacuum, and
exposed to X-ray films overnight.
Post-natal lethality of Sp3 knockout mice
Western blotting
Nuclear extracts (6 µg of protein) were prepared from mouse embryonic
E18.5 brains according to Gorski et al. (1986), separated on 10% SDS–
polyacrylamide gels, blotted on nitrocellulose or PVDF membranes, and
probed with a rabbit αSp3 serum (Hagen et al., 1994). Primary antibodies
were visualized using the Amersham ECL kit.
Northern blot analyses
Total RNA from embryonic mouse tissues and cell lines was extracted
by the guanidinium/isothiocyanate procedure using the Qiagen kit.
RNA was separated through 0.8 and 1.2% agarose gels containing
2.2 M formaldehyde and blotted to nylon membranes. Pre-hybridization
and hybridization were carried out as described (Braun and Suske,
1998). Gene-specific probes were obtained from appropriate plasmids
or primer sets. Detailed information is available upon request.
Morphological analysis
Embryos were dissected at day 18.5 post-coitum, and a small tail snip
was removed for genotyping. Fetuses were cut in half longitudinally and
fixed in Carnoy’s solution (60% ethanol, 30% chloroform, 10% acetic
acid) at 4°C overnight and embedded in paraffin according to standard
procedures. Sections were stained with hemalaun and either eosin (HE)
or periodic acid–Schiff (PAS) reagent. For electron microscopy, lung
tissue samples were cut into small pieces of ~1 mm3 and immersion
fixed with 2.5% paraformaldehyde, 2.5% glutaraldehyde and 0.05%
picrinic acid in 0.067 M cacodylate buffer pH 7.4 for 2 h at 4°C.
Standard procedures for dehydration and embedding in Epon were
employed. Thin sections were stained with uranyl acetate and lead
citrate, and examined in an EM 109 electron microscope (Zeiss).
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